2023-12-19 | Company
Company report 2022
During 2022, we initiated the expansion of the R&D capacity at our US site in Putnam and increased our capabilities with a new line for aseptic fill and finish. Read the full company report.
2023-12-19 | Company
During 2022, we initiated the expansion of the R&D capacity at our US site in Putnam and increased our capabilities with a new line for aseptic fill and finish. Read the full company report.
2023-10-18 | Company
We pleased to announce the approval by the Swedish Health authorities of its state-of-the-art aseptic filling line for syringes, specifically designed for high potent injectable drugs, at its Malmo site.
2023-10-11 | Company
We are happy to announce that Kristian Ahlgren has been appointed as Director of Supply Chain Management.
2023-09-21 | Company
[Putnam, CT, USA - Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites.
2023-09-13 | Company
Tony Listro, Vice President of Technology and Site Lead for SPS’s North American site in Putnam, CT, discusses the company’s recent focus areas and current expansion plans.
2023-07-07 | Company
Sustainability is front and center for a company of our kind. Subsequently, Sever Pharma Solutions is entirely focused on human health and well-being. Read the full sustainability report.
2022-10-13 | Company
Our goal is to build a global CDMO with a niche strategy. There are few high-potency product manufacturers, and almost no one works with polymer implants. Read the full company report.